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MAGNETIC RESONANCE IMAGING OF
VENTILATION AND PERFUSION IN THE
LUNG
CROSS-REFERENCE TO RELATED
APPLICATION
This patent document claims priority of U.S. Provisional
Patent Application No. 61/420,554, filed Dec. 7, 2010,
entitled "IMAGING VENTILATION AND PERFUSION
IN THE LUNG USING MRI". The entire content of the
before-mentioned patent application is incorporated by ref-
erence as part of the disclosure of this application.
STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH OR DEVELOPMENT
This invention was made with government support under
grants E13005970, HL080203, and HL081171 awarded by
the National Institutes of Health (NIH), along with a
National Aeronautics and Space Administration (NASA)
grant NCC9-58 #PF02103, awarded through the National
Space Biomedical Research Institute (NSBRI). The govern-
ment has certain rights in the invention.
BACKGROUND
This patent document relates to magnetic resonance
image (MRI) technologies.
The lungs are primarily responsible for gas exchange, as
well as a number of other functions. Ventilation of the lungs
refers to the intake and removal of air in/out of the lungs,
which involves the mixing of inspired gas (inhaled gas that
is humidified and at body temperature) with alveolar gas for
gas exchange of oxygen (Oz) and carbon dioxide (CO2) in
the alveoli of the lungs. Perfusion refers to the delivery of
blood to capillary beds of a biological structure, e.g., alveoli
in the lungs.
MRI is a medical imaging technique that applies a mag-
netic field and a pulse of radio frequency (RF) energy to
produce an image used for imaging internal biological
structures, e.g., the lungs. MRI is based on the property of
nuclear magnetic resonance (NMR). NMR is a physical
property in which the nuclei of atoms absorb and re-emit
electromagnetic energy at a specific resonance frequency in
the presence of a magnetic field. The absorption and reemis-
sion of energy can be dependent on the strength of the
magnetic field and the magnetic property of the atoms (e.g.,
atoms whose nuclei possesses magnetic spin).
SUMMARY
Techniques, systems, and devices are disclosed for imple-
menting a quantitative, non-injectable contrast MRI tech-
nique to measure spatial ventilation-perfusion matching.
In one aspect of the disclosed technology, a method using
magnetic resonance imaging to characterize ventilation and
perfusion in a lung includes acquiring a magnetic resonance
(MR) image of the lung that includes MR data in a voxel of
the MR image, which includes obtaining a breathing fre-
quency parameter, determining a water density value, a
specific ventilation value, and a perfusion value in at least
one voxel of the MR image based on the MR data, which the
water density value is used to determine an air content value,
and determining a ventilation-perfusion ratio value that is
2
the product of the specific ventilation value, the air content
value, the inverse of the perfusion value, and the breathing
frequency.
Various implementations of the above aspect can include
5 one or more of the following features. The method can
include the MR image being a 2D image. The method can
include the MR image being a 3D image. The method can
include determining the ventilation-perfusion ratio value
voxel-by-voxel. The method can include acquiring the MR
io image using oxygen as an inhaled contrast agent. The
method can further include determining an alveolar venti-
lation value that is the product of the specific ventilation
value, the air content value, and the breathing frequency.
The method can include producing a spatial distribution of
15 ventilation, perfusion, and ventilation-perfusion using the
ventilation-perfusion ratio value, the alveolar ventilation
value, and the perfusion value. The method can include
producing an image that shows the spatial distribution of
ventilation, perfusion, and ventilation-perfusion for each
20 voxel associated with the acquired MR image, and the
spatial distribution of ventilation, perfusion, and ventilation-
perfusion can be used as an indicator of a healthy or a
diseased lung. The method can include determining venti-
lation-perfusion matching in the lung based on the ventila-
25 tion-perfusion ratio value, and ventilation-perfusion match-
ing can be used as an indicator of a healthy or a diseased
lung.
In another aspect, an MRI system to characterize venti-
lation and perfusion in a lung includes an MRI machine and
3o a processing unit. The MRI machine acquires an MR image
of the lung. The processing unit is configured to command
the magnetic resonance imaging machine to acquire the MR
image that includes MR data in each voxel of the MR image,
process the MR data to determine a water density value, a
35 specific ventilation value, and a perfusion value in at least
one voxel of the MR image, in which the water density value
is used to determine an air content value, and determine a
ventilation-perfusion ratio value that is the product of the
specific ventilation value, the air content value, the inverse
40 of the perfusion value, and a breathing frequency.
Various implementations of the above aspect can include
one or more of the following features. The MRI system can
use oxygen as an inhaled contrast agent to acquire the MR
image of the lung. The processing unit can also be config-
45 ured to determine an alveolar ventilation value that is the
product of the specific ventilation value, the air content
value, and the breathing frequency. The processing unit can
also be configured to produce a spatial distribution of
ventilation, perfusion, and ventilation-perfusion using the
50 ventilation-perfusion ratio value, the alveolar ventilation
value, and the perfusion value. The processing unit can also
be configured to produce an image that shows the spatial
distribution of ventilation, perfusion, and ventilation-perfu-
sion for each voxel associated with the acquired MR image.
55 The spatial distribution of ventilation, perfusion, and venti-
lation-perfusion can be used as an indicator of a healthy or
a diseased lung. The processing unit can also be configured
to determine ventilation-perfusion matching in the lung
based on the ventilation-perfusion ratio value, and ventila-
60 tion-perfusion matching can be used as an indicator of a
healthy or a diseased lung.
In another aspect, a computer program product compris-
ing a nonvolatile computer readable storage medium having
instructions stored thereon includes code for acquiring an
65 MR image of a lung that includes MR data in a voxel of the
MR image, code for determining a water density value, a
specific ventilation value, and a perfusion value in at least
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one voxel of the MR image based on the MR data, in which
the water density value is used to determine an air content
value, and code for determining a ventilation-perfusion ratio
value that is the product of the specific ventilation value, the
air content value, the inverse of the perfusion value, and a 5
breathing frequency value.
Various implementations of the above aspect can include
one or more of the following features. The code for acquir-
ing the MRI image of the lung can include code using
oxygen as an inhaled contrast agent. The nonvolatile com- io
puter readable storage medium can further include code for
determining an alveolar ventilation value that is the product
of the specific ventilation value, the air content value, and
the breathing frequency. The code for determining the
alveolar ventilation value can include code for producing a 15
spatial distribution of ventilation, perfusion, and ventilation-
perfusion using the ventilation-perfusion ratio value, the
alveolar ventilation value, and the perfusion value. The code
for determining the alveolar ventilation value can also
include code for producing an image that shows the spatial 20
distribution of ventilation, perfusion, and ventilation-perfu-
sion for each voxel associated with the acquired MR image.
The nonvolatile computer readable storage medium can
further include code for using the spatial distribution of
ventilation, perfusion, and ventilation-perfusion to indicate a 25
healthy or a diseased lung. The nonvolatile computer read-
able storage medium can further include code for determin-
ing ventilation-perfusion matching in the lung based on the
ventilation-perfusion ratio value. The code for determining
ventilation-perfusion matching can further include code for 30
using ventilation-perfusion matching to indicate a healthy or
a diseased lung.
In another aspect, a method implementing a proton mag-
netic resonance imaging technique using oxygen as a con-
trast agent to quantify regional specific ventilation in a lung 35
with magnetic resonance imaging includes acquiring TI
weighted images of a slice of a lung of a subject, in which
the images are voluntarily respiratory gated by having the
subject take a single breath following each image and then
relax to functional residual capacity in time for a subsequent 40
image, and detecting alterations in the images associated
with a regional rise in oxygen concentration that reflect
specific ventilation.
Various implementations of the above aspect can include
one or more of the following features. The method can 45
include acquiring TI weighted images without a hyperpo-
larized gas. The T  weighted images can be 2D images. The
TI weighted images can be 3D images. The acquiring TI
weighted images can use oxygen as an inhaled contrast
agent. The method can further include producing an image 50
that shows specific ventilation for each voxel associated
with the acquired MR image. The method can include the
specific ventilation being used as an indicator of a pulmo-
nary pathological condition.
The disclosed technology can provide one or more of the 55
following advantages. For example, the described methods,
devices and systems can provide a fully quantitative non-
injectable contrast agent proton MRI technique to measure
spatial ventilation-perfusion (V,/Q) matching and spatial
distribution of ventilation and perfusion. The disclosed MRI 60
techniques can be performed using an MRI system such as
a standard 1.5 T clinical scanner, which can allow routine
clinical imaging of patients. Implementation of the disclosed
techniques can allow quantitative, noninvasive evaluation of
important aspects of lung function. Implementation of the 65
disclosed techniques can eliminate contrast injection and/or
radiation hazard. This can be important for repeated evalu-
4
ations, such as for research applications, and for screening
patients with genetic predispositions to lung disease and
with diseases such as collagen vascular diseases that have
pulmonary manifestations.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows an exemplary MRI-based ventilation-per-
fusion matching system.
FIGS. 2A-2D show diagrams of an exemplary MRI-based
ventilation-perfusion method to characterize spatial VA/Q
matching from MR images.
FIG. 3A shows an exemplary quantitative image of
regional specific ventilation.
FIG. 3B shows an exemplary quantitative image of
regional air content.
FIG. 3C shows an exemplary quantitative map of regional
alveolar ventilation.
FIG. 4A shows an exemplary quantitative image of per-
fusion.
FIG. 4B shows an exemplary quantitative measure of
regional ventilation-perfusion ratio.
FIGS. 5A and 5B show exemplary plots of the spatial
distribution of VA, Q and VA/Q.
FIG. 6 shows an exemplary plot of specific ventilation of
a lung unit.
FIG. 7A shows an exemplary plot correlation delay time.
FIG. 7B shows an exemplary plot of the relationship of
correlation delay to specific ventilation.
FIG. 8 shows an exemplary time series of signal intensity
for a single voxel.
FIG. 9A shows an exemplary correlation delay time map
in a sagittal slice of the lung.
FIG. 9B shows an exemplary corresponding specific
ventilation map.
FIG. 10 shows an exemplary graph of specific ventilation
for each lung region.
FIGS. 11A, 11B, and 11C show exemplary graphs of
specific ventilation plotted versus the vertical distance from
the most dependent portion of the lung.
Like reference symbols and designations in the various
drawings indicate like elements.
DETAILED DESCRIPTION
Techniques, devices and systems are described for imple-
menting a quantitative, non-injectable contrast MRI tech-
nique to measure spatial ventilation-perfusion matching.
A primary function of the lung is gas exchange. The
efficiency of gas exchange can be determined by matching
of delivery of fresh gas by alveolar ventilation (V,) to local
perfusion (Q). VA/Q matching can be affected by passive
mechanisms such as anatomical matching of the branching
airway and blood vessel structures and by active mecha-
nisms such as hypoxic pulmonary vasoconstriction. VA/Q
matching can be used to characterize processes in which
regions of the lung that receive fresh gas also receive
deoxygenated capillary blood. Therefore, precise VA/Q
matching within the millions of gas exchange units can be
considered a fundamental mechanism to determine the effi-
ciency of the gas exchange process, which can provide
information on health and disease.
The measurement of ventilation-perfusion (VA/Q) match-
ing can be used as an indicator to distinguish between
healthy or diseased lungs. For example, in normal or healthy
lungs, the matching of ventilation to perfusion is relatively
uniform, e.g., the mean and variance of VA/Q ratios are
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substantially identical for both ventilation and perfusion,
and regions of high ventilation also receive high perfusion,
with regions of low ventilation receiving low perfusion. For
example, optimal VA/Q matching in the lung can be asso-
ciated with tight, narrow, clusters of matched VA and Q or
with broader, highly correlated distributions of VA and Q. In
some cases, a broadening of the distributions with a main-
tained VA/Q matching can be considered as ` stressed' VA/Q
matching although matching is preserved, the lung may be
at risk. For example, the lung can be considered overbuilt for
many of the demands of daily life (except for the most
strenuous exercise), and a region of loss of function may be
compensated for by the remaining normal lung, which may
delay diagnosis. Measurement of the separate spatial distri-
bution of VA and Q as well as overall VA/Q can allow
detection of this compensation. Therefore, it can be impor-
tant to measure the spatial distribution of VA and Q as well
as overall VA/Q matching.
VA/Q mismatch can be associated with lung disease, such
as airway predominant diseases including asthma and dis-
eases affecting the pulmonary circulation including pulmo-
nary arterial hypertension (PAH). Lung disease is a leading
cause of morbidity and mortality in the world. Various types
of lung disease can be characterized by disruption of VA/Q
matching, resulting in gas exchange inefficiency. For
example, decreased VA/Q matching can be a hallmark of
chronic obstructive pulmonary disease (COPD), with areas
of both high VA/Q ratio (deadspace) and low VA/Q ratio
described, and an overall decrease in VA/Q matching. Simi-
larly, pulmonary hypertension, asthma, pulmonary edema,
pulmonary fibrosis and adult respiratory distress syndrome
can also be characterized by VA/Q mismatch.
For example, in patients with advanced lung disease, a
diagnosis can be clinically observable, which can be con-
firmed with some diagnostic tools. Despite this, existing
diagnostic tools such as spirometry can lack sensitivity and
specificity, which may limit their utility for early diagnosis.
For example, spirometry is not defined as abnormal until on
average the patient has lost 20% of lung function. This can
suggest that the normal compensatory mechanisms of the
lung can prevent early detection of abnormalities, and can
delay diagnosis and treatment. For example, a highly inva-
sive and sparsely available diagnostic tool known as mul-
tiple inert gas elimination technique (MIGET) has been
shown to be capable of identifying markedly abnormal VA/Q
matching in patients with mild COPD (GOLD stage 1);
while in the same patients, the changes in spirometry were
shown to be mild and arterial oxygen and carbon dioxide
levels were largely normal. This disruption of VA/Q match-
ing in these patients can suggest that a quantitative technique
to measure VA/Q matching can offer the ability to detect
pre-clinical disease in COPD. Similarly, patients with pul-
monary hypertension often do not present for medical care
until the disease is well advanced. Pulmonary hypertensive
patients also may have marked disruption of VA/Q matching
at the time of diagnosis, suggesting that increased VA/Q
mismatch can be an early feature of the disease. The
disclosed technology can include a quantitative measure-
ment of spatial VA/Q matching that can be used to enhance
early disease identification and provide a noninvasive tool
for monitoring disease progression and response to therapy,
as well as quantitatively address research questions related
to disease mechanisms.
The disclosed technology described in this patent docu-
ment can be used to directly measure whole lung and spatial
VA/Q matching in a manner that is fully quantitative, non-
invasive, without radiation exposure, and clinically relevant
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(e.g., applicable and accessible to human patients). Imple-
mentation of the disclosed technology can provide the
ability to measure spatial VA/Q matching and spatial distri-
bution of ventilation and perfusion, which can, for example,
5 be performed on a standard 1.5 T clinical scanner at the level
of the gas exchange unit. Measured VA/Q matching and
spatial distribution of VA and Q can be used to evaluate
mechanisms of lung disease, injury, response to treatment
and repair. For example, the disclosed techniques may be
io used in screening populations of patients at risk of devel-
oping lung disease and for monitoring response to treatment
in those already afflicted. Routine clinical imaging of
patients can be performed using the disclosed technology,
e.g., allowing quantitative and noninvasive evaluations of
15 the of lung function without concerns of radiation hazards
and contrast injections.
In one aspect of the disclosed technology, three quanti-
tative non-injectable contrast proton MRI techniques, that
when implemented together, can allow regional ventilation,
20 perfusion and spatial VA/Q matching to be directly mea-
sured, e.g., in the entire lung in humans. The measured
values can be based on regions of the lungs. For example,
MR images of the lung of a subject can be partitioned into
three gravitational regions, corresponding to thirds of the
25 lung based on equal vertical extent, e.g., a dependent region
(region which is lowest with respect to the direction of the
gravity vector); an intermediate region (region between
dependent and non-dependent regions); and the non-depen-
dent region (region which is highest with respect to the
so direction of the gravity vector). One technique of the dis-
closed technology can include a T2* multi-echo, fast gra-
dient echo (mGRE) sequence for the rapid measurement of
lung density (fractional water) in g (of water)/cm'. Another
technique of the disclosed technology can include a specific
35 ventilation imaging (SVI) technique, which can use oxygen
as a contrast agent for the measurement of regional specific
ventilation, e.g., the dimensionless ratio of tidal volume
(fresh gas) to functional residual capacity (residual gas at the
end of a normal exhalation) of each lung element. Another
40 technique of the disclosed technology can include an arterial
spin labeling (ASL) technique, which can directly quantify
regional pulmonary blood flow (perfusion) in units of mL (of
blood)/min/cm3. The disclosed MRI technology can apply
appropriate scaling such that the measurements provided by
45 the three exemplary techniques (e.g., mGRE, SVI, and ASL
techniques) can be processed to provide quantitative spatial
VA/Q matching and spatial distribution of VA and Q, e.g., on
a voxel by voxel basis. For example, by combining the
measured specific ventilation data with proton density mea-
50 surements, alveolar ventilation (VA) can be determined, such
that when combined with perfusion measurements, can
provide a fully quantitative measure of VA/Q used to deter-
mine VA/Q matching. For example, the disclosed MRI
technology can measure TI enhancement as a function of
55 breath number to calculate an oxygen wash-in, and from
that, be used to determine specific ventilation. Separate
proton density measures can then be used to calculate VA
from specific ventilation, and combined with separate mea-
sures of perfusion giving a fully quantitative measure of
60 ventilation-perfusion matching.
FIG. 1 shows an exemplary MRI-based ventilation-per-
fusion matching system (100) for providing a quantitative,
noninvasive measure of spatial VA/Q matching. FIG. 1
shows one aspect of the exemplary system (100) that can
65 include a magnetic resonance imaging (MRI) machine
(110), which can be controlled by a MR image processing
unit (120).
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The exemplary MRI machine (110) can be used in the
system (100) to implement a MRI-based ventilation-perfu-
sion matching characterization process under the control of
the exemplary MR image processing unit (120). MRI
machine (110) can include various types of MRI systems, 5
which can perform at least one of a multitude of MRI scans
that can include, but are not limited to, TI-weighted MRI
scans, T2-weighted MRI scans, T2*-weighted MRI scans,
spin (proton ('H)) density weighted MRI scans, diffusion
tensor (DT) and diffusion weighted imaging (DWI) MRI io
scans, Tlp MRI scans, magnetization transfer (MT) MRI
scans, real-time MRI, functional MRI (fMRI) and related
techniques such as arterial spin labeling (ASL), among other
MRI techniques.
The exemplary MR image processing unit (120) can 15
include a processor (121) that can be in communication with
an input/output (I/O) unit (122), an output unit (123), and a
memory unit (124). MR image processing unit (120) can be
implemented as one of various data processing systems,
such as a personal computer (PC), laptop, tablet, and mobile 20
communication device. To support various functions of MR
image processing unit (120), the exemplary processor (121)
can be included to interface with and control operations of
other components of MR image processing unit (120), such
as the exemplary I/O unit (122), the exemplary output unit 25
(123), and the exemplary memory unit (124).
To support various functions of the MR image processing
unit (120), memory unit (124) can store other information
and data, such as instructions, software, values, images, and
other data processed or referenced by processor (121). 30
Various types of Random Access Memory (RAM) devices,
Read Only Memory (ROM) devices, Flash Memory devices,
and other suitable storage media can be used to implement
storage functions of memory unit (124). The exemplary
memory unit (124) can store MRI data and information, 35
which can include subject MRI image data including spatial
and spectral data. MRI machine system parameters, data
processing parameters, and processed parameters and data
that can be used in the implementation of a VA/Q matching
characterization. Memory unit (124) can store data and 40
information that can be used to implement a MRI-based
VA/Q matching characterization process and that can be
generated from a MRI-based VA/Q matching characteriza-
tion algorithm and model.
To support various functions of the MR image processing 45
unit (120), the exemplary I/O unit (122) can be connected to
an external interface, source of data storage, or display
device. Various types of wired or wireless interfaces com-
patible with typical data communication standards, such as
Universal Serial Bus (USB), IEEE 1394 (FireWire), Blu- 50
etooth, IEEE 802.111, Wireless Local Area Network
(WLAN), Wireless Personal Area Network (WPAN), Wire-
less Wide Area Network (WWAN), WiMAX, IEEE 802.16
(Worldwide Interoperability for Microwave Access (Wi-
MAX)), and parallel interfaces, can be used to implement 55
I/O unit (122). I/O unit (122) can interface with an external
interface, source of data storage, or display device to retrieve
and transfer data and information that can be processed by
the processor (121), stored in the memory unit (124), or
exhibited on the output unit (123). 60
To support various functions of the MR image processing
unit (120), the output unit (123) can be used to exhibit data
implemented by the exemplary MR image processing unit
(120). The output unit (123) can include various types of
display, speaker, or printing interfaces to implement the 65
exemplary output unit (123). For example, the output unit
(123) can include cathode ray tube (CRT), light emitting
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diode (LED), or liquid crystal display (LCD) monitor or
screen as a visual display to implement the output unit (123).
In other examples, the output unit (123) can include toner,
liquid inkjet, solid ink, dye sublimation, inkless (such as
thermal or UV) printing apparatuses to implement the output
unit (123); the output unit (123) can include various types of
audio signal transducer apparatuses to implement the output
unit (123). The output unit (123) can exhibit data and
information, such as patient diagnostic data, MRI machine
system information, partially processed MRI-based VA/Q
matching characterization processing information, and com-
pletely processed MRI-based VA/Q matching characteriza-
tion processing information. The output unit (123) can store
data and information used to implement a MRI-based VA/Q
matching characterization process and from an implemented
MRI-based VA/Q matching characterization process.
FIG. 2A shows a process flow diagram that describes
implementation of an exemplary MRI-based ventilation-
perfusion method to measure spatial VA/Q matching from
MR images, e.g., from the lung that can be used to assess
lung function. Exemplary methods to characterize lung
functionality using MRI techniques, such as water density
measurement, specific ventilation measurement, alveolar
ventilation measurement, perfusion measurement, ventila-
tion-perfusion ratio measurement, and ventilation-perfusion
matching, can be performed on systems and devices, such as
the exemplary system (100) illustrated in FIG. 1. For
example, FIG. 2A shows an exemplary method (200) to
characterize spatial V,/Q matching from MR image(s) that
includes a process (210) to determine lung density (water
fraction) values from an MR image of a lung in a desired
target, a process (220) to determine regional specific venti-
lation values from an MR image of the lung in the desired
target, a process (230) to determine regional pulmonary
perfusion values in an MR image of the lung in the desired
target, and a process (240) to determine spatial ventilation-
perfusion matching in the lung of the desired target, e.g., by
combining and processing the resultant values process
(210), process (220), and process (230). Process (240) can
also include characterizing the spatial distribution of venti-
lation and perfusion. Exemplary method (200) can imple-
ment exemplary processes (210), (220), and (230) in the
order shown in FIG. 2A, or in any other order not shown in
the exemplary figure.
Process (210) can include performing MR imaging on an
MRI machine, e.g., MRI machine (110), using 2D or 3D
multiple gradient-recalled echo (mGRE) sequence and/or
other types of sequence. Process (210) can characterize
regional lung water density (water fraction) by using an
exemplary mGRE sequence technique to provide rapid
acquisition of lung proton density data on a voxel by voxel
basis. For example, lung proton density data can be acquired
at rates —8 seconds/slice. The described mGRE sequence
technique can provide a measurement of regional lung water
compensated for potential differences in T2*.
The exemplary mGRE sequence technique can include a
pulse sequence of a small flip angle slice selective excitation
followed immediately by the collection of a single full line
of Fourier data. The sequence can acquire data at 2 echo
times, and the proton density of the lung can be determined
by back extrapolating the signal to an echo time (TE), e.g.,
TE-0, by fitting data points to a single exponential.
FIG. 2B shows a diagram of an exemplary 2D acquisition
sequence to determine lung density (water fraction) values
in process (210). In this example, process (210) can include
process (211) that includes collecting 2D MRI images in
sequential slices across the lung field, e.g., at 2 echo times.
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Implementation of the exemplary 2D acquisition sequence
on a slice with a thickness of substantially 15 mm can be
covered over the entire lung in approximately 9 minutes
(e.g., —18 slices*10 sec per scan, 20 sec recovery). The
exemplary 2D acquisition sequence to acquire MRI images
in process (211) can include a single RE pulse followed by
a single full line of Fourier data. It is noted that acquisition
time is limited by breath-hold time (e.g., less than 12
seconds in some patient populations. Process (212) includes
phase encoding the acquired image(s) at a fixed echo time
(TE) and repetition time (TR) until k-space is filled for a
single image. The sequence can then repeat by filling
k-space acquired at a second echo time while keeping TR
constant. Process (213) includes processing the phase
encoded data, e.g., by fitting the data points to a single
exponential decay function, to determine lung water density,
as well as T2*. The exemplary mGRE sequence technique
exemplified in FIG. 2B can be adapted from a 2D acquisition
sequence to a 3D acquisition sequence. For example, an
exemplary 3D acquisition sequence can be implemented in
which one 3D image is acquired at each echo time (e.g., two
3D volumes), shortening acquisition time. For example, a
single lung volume may be acquired in 6 seconds with an
isotropic resolution of 8 mm3 with the following sequence
parameters: echo time-0.7 ms and 1.2 ms, field of view-30
cm (A/P)x48 cm (R/L)x48 cm (S/I), repetition time2.5 ms,
flip angle=5°, matrix acquisition40 (A/P)x64(R/L)x64
(S/I), and can increase in signal-to-noise ratio (SNR).
Process (220) can include performing proton MR imaging
on an MRI machine, e.g., MRI machine (110). Process (220)
can characterize specific ventilation (SV) and regional ven-
tilation by using an exemplary specific ventilation imaging
(SVI) technique. Specific ventilation (SV) is a measure of
regional ventilation that can be determined by the ratio of
fresh gas entering a lung region divided by its end-expira-
tory volume. Specific ventilation (SV) can be defined as the
ratio of the volume of fresh gas (AV) moving into a region
of the lung to the end-expiratory volume (Vo) of that region,
SV=AV/V,.
The exemplary SVI technique can be implemented in a
single or multiple lung slice enabling two dimensional (21))
and three dimensional (31)) SV characterizations. The exem-
plary SVI technique can use 100% oxygen as a contrast
agent. The SVI technique can include oxygen delivery to
and dissolution in lung tissue, which can shorten the longi-
tudinal relaxation time (TJ, increasing the local MRI signal.
For example, T,-weighted images can be acquired while a
subject breathes air and then 100% 02 in an alternating
sequence. Since the amount of regional dissolved oxygen
can be associated with the amount of oxygen locally avail-
able (e.g., determined by ventilation), the oxygen wash-in
time for individual voxels can be determined. Voxels that
have a high specific ventilation can reach the new equilib-
rium faster than units that are less ventilated. A quantitative
measure of the specific ventilation (e.g., local tidal volume/
functional residual capacity (FRC)) of that portion of the
lung can be determined, for example, considering the time
delay between the onset of the stimulus (breathing 100%
oxygen) and the response for a particular voxel.
FIG. 2C shows a diagram of an exemplary MRI imaging
technique to determine to regional specific ventilation values
in process (220). In this example, process (220) can include
process (221) that includes acquiring 2D T, weighted MRI
images, e.g., using an inversion recovery single shot fast
spin echo sequence with images being acquired with a half
Fourier acquisition. The exemplary process (221) can
include using an inversion time of 1000 msec. Process (222)
10
includes producing a signal intensity time series of the
acquired MRI images and determining the correlation delay
time using a shifted cross correlation between the inspired
fractional oxygen concentration and the acquired signal
5 intensity time series. Process (223) includes processing the
correlation delay time to determine specific ventilation val-
ues, e.g., regional specific ventilation values, as described in
further detail later in this patent document. Process (223) can
also include producing a plot or map of the specific venti-
io lation values. The exemplary SVI technique is not limited to
2D MRI acquisitions. The exemplary technique exemplified
in FIG. 2C can be adapted from a 2D MRI technique to a 3D
MRI technique.
Exemplary techniques to implement 3D ventilation imag-
15 ing can be accomplished in a reasonable acquisition time,
e.g., by co-registering with the proton density images,
specific ventilation can be converted to VA as previously
described. The exemplary SVI technique can map the
change in signal intensity due to the local change in oxygen
20 concentration effect on T, This contrast change can be
enhanced by adding a global inversion recovery pulse prior
to acquisition. As a result, 3D sampling techniques can be
implemented to acquire the entire lung field. For example,
one approach includes improving the acquisition speed
25 (short T2 in the lung) by a single-shot GRASE acquisition
which can allow multiple 2D images to be acquired follow-
ing an inversion pulse. Another approach includes imple-
menting highly constrained back-projection for time-re-
solved MRI (HYPR) or vastly under-sampled isotropic
30 projection reconstruction (VIPR) to significantly reduce the
acquisition time and the echo time, thereby improving the
overall SNR while allowing full 3D acquisition of the lung.
Process (230) can include performing MR imaging on an
MRI machine, e.g., MRI machine (110), using 2D or 3D
35 calibrated arterial spin labeling (ASL) technique and/or
other technique. Process (230) can characterize the distri-
bution of pulmonary perfusion by using the exemplary ASL
technique to provide analysis of how the normal distribution
of perfusion can be disrupted by a variety of insults, such as
4o hypoxia, exercise and interstitial pulmonary edema. The
described ASL technique can be respiratory and cardiac
gated and fully quantitative.
The exemplary ASL technique can be used to quantify
pulmonary perfusion using a 2D arterial spin labeling
45 flow-sensitive alternating inversion recovery with an extra
radio frequency pulse (ASL-FAIRER) sequence with a
half-Fourier acquisition single-shot turbo spin-echo
(HASTE) imaging scheme. For example, two ECG-gated
images (to collect data from a complete systolic ejection
50 period) of each of the selected slices can be taken (e.g., 4 to
6 seconds apart, depending on heart rate) during two suc-
cessive apneas with the glottis open at the desired lung
volume. The images can be preceded by tagging pulses that
invert the magnetization of arterial blood outside the imag-
55 ing plane in one case, and leave it undisturbed in the other.
Pairs of images so obtained can be subtracted, leaving an
image of pulmonary blood flow delivered during one cardiac
cycle. The orientation of the imaged slices of lung can be
varied as desired. One example includes the sagittal plane,
6o and voxel sizes of approximately 1.6x1.6x15 mm (-36 mm3
or 0.04 cm3) can be visualized.
FIG. 2D shows a diagram of an exemplary MRI imaging
technique to determine to regional perfusion values in
process (230). In this example, process (230) can include
65 process (231) that includes acquiring 2D MRI images, e.g.,
an ASL-FAIRER sequence with a HASTE imaging scheme
in sequential slices. In FAIRER, an image is acquired by
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applying a spatially selective inversion pulse, followed by a
saturation pulse, followed by dephasing gradients. An
adequate delay can allow relaxed spins to enter from adja-
cent tissue and displace saturated spins. Imaging can begin
after this delay. The imaging slice and inversion slice can be 5
centered on the same plane to overlap. Complete inversion
of the spins in the image plane can include making the width
of the selective inversion pulse substantially wider than the
image slice thickness. This can be repeated with the spatially
10
selective inversion pulse replaced by a nonspatially-selec-
tive inversion pulse. This can, for example, invert all of the
spins in the volume covered by the RE body coil. The same
delay can allow inverted spins to enter the imaging plane.
Process (232) can include producing a perfusion-weighted 15
image map, e.g., by subtraction of the spatially-selective
tagged image from the non-spatially-selective tagged image.
It is noted that the addition of the extra RE pulse and
dephasing gradients, for example, can prevent the zeroing of
signal intensity in certain voxels upon subtraction. Process 20
(233) can determine regional pulmonary perfusion values by
extracting perfusion data from the produced perfusion-
weighted image map.
An exemplary 3D ASL acquisition technique to acquire
perfusion data in the lung can include collecting each 25
tag/control pair in sequential slices such that the entire
dataset encompasses the entire lung. Data for each sagittal
slice can be collected during sequential breath holds at
functional residual capacity moving from the medial chest
adjacent to the mediastinum to the lateral chest wall. A 30
complete 3D lung dataset may only take —3 minutes to
acquire with respiratory gating between repetition times,
e.g., —5 sec. This whole sequence can be repeated for signal
averaging or to ensure image quality. A more complex, but
more efficient, approach for 3D ASL data acquisition can 35
include interleaving the ASL with the SVI acquisition,
shortening the combined acquisition time for the two
images.
FIGS. 3A, 3B and 3C show exemplary quantitative
images of regional specific ventilation (FIG. 3A) and 40
regional air content (FIG. 313) to produce a map of regional
alveolar ventilation (FIG. 3C) in a single sagittal slice from
the right lung of an exemplary human subject in the supine
position. FIG. 3A shows quantitative image (301) that
exemplifies regional specific ventilation in the exemplary 45
slice by implementing process (220). FIG. 3B shows quan-
titative image (302) that exemplifies regional air content in
the exemplary slice by implementing process (210). FIG. 3C
shows quantitative image (303) that exemplifies regional
alveolar ventilation (V,) determined on a voxel by voxel 50
basis in the exemplary slice by implementing process (240).
The exemplary color scale represents regional alveolar ven-
tilation in L•min i. The exemplary arrow (310) in FIGS. 3A,
313, and 3C indicates the gravitational vector. As seen in
FIGS. 3A and 3C, the exemplary quantitative image values 55
of both specific ventilation image (301) and regional venti-
lation image (303) are greater in the gravitationally depen-
dent region of the lung. This result may indicate, for
example, that the nondependent region of the lung is already
stretched and relatively poorly ventilated. 60
FIGS. 4A and 4B show exemplary quantitative images of
ASL measure of perfusion (FIG. 4A), which when combined
with the measure of alveolar ventilation (303) can provide
regional VA/Q ratio (FIG. 413). The exemplary data shown in
FIGS. 4A and 4B were analyzed from the exemplary sagittal 65
slice of the subject as shown in FIGS. 3A-3C. FIG. 4A
shows quantitative image (401) that exemplifies ASL mea-
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sured perfusion data in the exemplary slice by implementing
process (230). The exemplary arrow (410) indicates the
gravitational vector.
FIG. 4B shows quantitative image (402) that exemplifies
the regional ventilation-perfusion ratio in the exemplary
slice by implementing process (240). In this exemplary
implementation, the sagittal plane was chosen to demon-
strate the well-known gravitational gradients in ventilation,
perfusion and VA/Q ratio. In the example shown in FIG. 413,
the regions of higher VA/Q ratio are seen in the nondepen-
dent region of the lung. In the example, regions consistent
with large vessels can be mapped as regions of shunt VA/Q
(e.g. VA/Q ratioO), as shown by arrow (420). The exem-
plary arrow (410) indicates the gravitational vector.
Process (240) can be used to determine spatial VA/Q
matching and spatial distribution of VA and Q by implemen-
tation of an exemplary MRI-based VA/Q matching technique
described herein. Specific ventilation can be measured in
process (220), e.g., having units of mL (fresh gas)/mL
(resident gas). Fractional lung density for any voxel can be
measured in process (210), e.g., having units of mL (water)/
cm3. In this context, both blood and other intra/extra-cellular
water can be considered as water. For example, a voxel in
the lung can include a mixture of water (fractional density 1)
and air (fractional density 0). Thus, the value of [1—density]
can be a direct measure of the air content of a voxel, which
can be measured in units of mL (resident gas)/cm3, e.g.,
within a small error resulting from any tissue not producing
an MRI signal.
The exemplary MRI-based VA/Q matching technique of
process (240) uses the combination of specific ventilation
(e.g., measured using the SVI technique in process (220))
and density (e.g., measured at FRC using the mGRE
sequence technique in process (210)) on a voxel by voxel
basis to provide a measure of fresh gas input to that voxel,
in units of [mL (fresh gas)/mL (resident gas)]•[mL (resident
gas)/cm3], e.g., mL (fresh gas)/cm3. For example, quantita-
tive data from an acquired SV image (e.g., image (301)) can
be multiplied by the breathing frequency (f,) in units of
min', which can be imposed by the repetition time used in
the SVI acquisition. The resultant value can be multiplied by
the value of [1—density] (e.g., quantitative data of air content)
to provide a fully quantitative measure of alveolar ventila-
tion (VA), in units of mL (fresh gas)/cm3/min. VA can be
determined for each voxel, which is represented in Eq. (1):
VA SVIx(1—density)xfB (1)
where SVI represents quantitative data from an acquired SV
image; (1—density) represents quantitative data of air con-
tent; and fB represents the breathing frequency.
For each voxel, a VA/Q ratio can be calculated by dividing
the resultant V, image data (e.g., image (303)) by the
quantitative value of perfusion in a voxel from an image
(e.g., image (401)), e.g., from quantitative perfusion data
measured using the ASL technique in process (230). VA/Q
can be determined for each voxel, which is represented in
Eq. (2):
VA/Q—[SVIx(1—density)/ASL]xfB (2)
where VA/Q represents a quantitative ratio of alveolar ven-
tilation to perfusion and ASL represents quantitative perfu-
sion data. From Eq. (2), VA/Q is represented in units of [mL
(fresh gas)]/[mL (blood)].
Process (240) can further include a process to evaluate
spatial distribution of VA, Q and VA/Q ratios, the relation-
ship of a(VA/Q), the standard deviation (SD) of VA/Q ratios
in logarithmic space, and a(V,) and a(Q), the SD of the
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individual ventilation and perfusion distributions (e.g., in
2D) logarithmic space. For example, after calculating the
voxel by voxel VA/Q ratio, some 5000-7000 points may be
left, which can then be probed in a variety of ways. For
example, plots of regional VA versus Q can be generated and
the histograms of the individual distributions (VA, Q, and
V,/Q) can be quantified. The correlation (r) between
regional VA/Q and VA and Q can be calculated. The variance
in the VA/Q heterogeneity can be related to the variance in
V, and Q as described by Eq. (3) and Eq. (4) in logarithmic
form:
6(VAIQ)Z-Cy(VA)Z+6(Q)Z-2-r-6(VA)6(Q) (3)
o2 log(VA/Q)-o2 log VA+a2 log Q-2r-a log VA-a
log Q (4)
where r is the correlation coefficient between VA and Q. Eqs.
(3) and (4) show that different sets of a(V,), a(Q), and r can
produce substantially identical a(VA/Q).
FIGS. 5A and 5B show two exemplary plots of the spatial
distribution of VA, Q and VA/Q for two healthy normal
subjects. Plot (501) shown in FIG. 5A features spatial
distribution of VA, Q and VA/Q of one normal healthy
subject. Plot (502) shown in FIG. 5B features spatial distri-
bution of VA, Q and VA/Q of the other normal healthy
subject. The diagonal red line (510) represents a VA/Q ratio
of 1. Voxels above line (510) have a V,/Q ratio above 1 (e.g.,
`higher' V,/Q ratio). Voxel points below line (510) have a
`lower' V,/Q ratio. Plot (501) and plot (502) exhibit the
overall VA/Q distribution slightly above 1, in which the
majority of points range between a VA/Q ratio of 0.5 and 3.
The range of VA/Q ratios can be considered important
because it can be shown that this is the range of VA/Q ratios
consistent with normal blood oxygenation and thus repre-
senting optimal VA/Q matching.
The exemplary method (200) can be implemented using
system (100) or other MRI systems. In one example imple-
menting the disclosed technology, MRI data can be collected
from the exemplary subjects using a 1.5 Tesla Signa HDx
TwinSpeed MRI system (e.g., General Electric Medical
Systems, Milwaukee, Wis., USA). MR images can be taken
from, for example, a single sagittal slice of the lung. A
subject can be placed supine in the MRI scanner wearing a
face mask (Hans Rudolph, Kans., USA), equipped with a
non-rebreathing T-valve. The inspiratory port of the T-valve
can be connected to a remote controlled valve allowing the
operator to change from room air to gas contained in a large
gas-tight bag filled from a gas cylinder in the control room.
The inspiratory paths can be matched in airflow resistance to
avoid any alteration in FRC when switching between them.
The outlet of the T-valve can be connected to a long (e.g., 6
m), low resistance expiratory line, e.g., leading out of the
scanner room, where expired tidal volume can be measured
(e.g., using a ParvoMedics Metabolic Measurement System,
(Sandy, Utah, USA)). Reference phantoms can be placed on
the anterior chest wall so as to be within the field of view of
the scans, permitting absolute quantification of blood flow
and lung density. The subject can lie on the posterior element
of an 8-channel cardiac coil, and the anterior elements are
placed directly on the chest wall.
The exemplary MRI VA/Q matching technique can be
implemented in 2D and 3D. 3D implementations of the
disclosed technology may include additional considerations,
e.g., accurate image registration at a sub-voxel resolution.
Other considerations that can exist in 3D implementations
can include effects on image registration from motion and
tissue deformation as lung volume at FRC has small varia-
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tions in subjects. Additionally, large blood vessels may
represent shunt VA/Q ratios (e.g., an absence of ventilation
that maps to a VA/Q ratio of zero) if a voxel represents an
imaged space entirely filled with blood. However, since
5 these large vessels are conduits, this does not represent a true
shunt, which is an important contribution to pulmonary gas
exchange abnormalities. The disclosed MRI VA/Q matching
technique can include mechanisms to eliminate the contri-
bution of large vessels from the image to accurately quantify
io true shunt. For large airways, these can be mapped as
deadspace (regions that are ventilated but not perfused).
Also, 3D implementations can involve longer data acquisi-
tion times than 2D, for example.
An important advantage of the disclosed techniques is that
15 there is no "dose" associated with performing measure-
ments, as there is no radiation or contrast injection to a target
subject. Thus, the disclosed technology can allow repeated
measurements to be performed on a subject under multiple
conditions. For example, this can further benefit biomedical
20 and physiological research design because each subject can
act as their own control.
In another aspect of the disclosed technology, specific
ventilation can be measured using proton MRI by using 02
as a contrast agent. Exemplary implementations of disclosed
25 techniques of this aspect can demonstrate a mapped distri-
bution of specific ventilation in the lung, e.g., including the
lung's gravitationally dependent gradient. Disclosed are
exemplary devices, systems, and methods to quantify spe-
cific ventilation (SV).
30 Specific ventilation is a dimensionless quantity that pro-
vides a measure of how efficiently a given lung region is
ventilated. For example, regional specific ventilation can be
an important metric from a physiological standpoint, as well
as also for clinical diagnosis and assessment of different
35 pulmonary pathological conditions, e.g., asthma, emphy-
sema, cystic fibrosis and lung cancer.
Oxygen is weakly paramagnetic, and when in solution in
lung tissues can produce a measurable decrease in the
longitudinal relaxation time TI of tissues, increasing the
40 signal intensity of an appropriately timed inversion recovery
proton MR image. An exemplary technique can include
using proton MRI technique in which inhaled oxygen (02)
can be used as a contrast agent to verify the presence or
absence of ventilation. Additionally, the disclosed technol-
45 ogy can obtain an 02-enhanced MRI signal that contains
more information than just the presence or absence of
ventilation. For example, the change in 02 concentration in
lung tissues (determining the local change in TI) depends on
the rate of change of the 02 alveolar concentration, which is
5o a function of the regional specific ventilation. Thus, mea-
surement of the regional rate of change of the MRI signal
can allow the quantification of specific ventilation: Follow-
ing a change in inspired fractional oxygen content (F1O2),
units that have higher specific ventilation reach the new
55 equilibrium faster than units that have a lower specific
ventilation. Thus, the rapidity of the change in the MRI
signal in a particular voxel or region following a change in
inspired F1O2 is a quantitative measure of the specific
ventilation of that portion of the lung.
60 In one example, following a sudden change in inspired
fraction of 02 (F 102), the rate of change of the alveolar 02
concentration is a function of the local specific ventilation,
e.g., lung units with higher specific ventilation reach a new
equilibrium faster than units with lower specific ventilation.
65 The time it takes to reach a new equilibrium is a measure of
the local specific ventilation. This time can be reflected in
the MR images. For a series of inversion recovery images
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acquired with appropriate scanning parameters, the signal
intensity change observed following a change in inspired gas
can be determined by the change in relaxation time TI, e.g.,
a change driven by the local amount of oxygen in solution,
which is a function of the local Oz partial pressure. The time
course of the regional MR signal intensity resulting from a
change in inspired Oz-concentration can therefore reflect
local specific ventilation. For example, the rapidity of the
increase in the MRI signal intensity following the onset of
Oz inhalation is directly related to specific ventilation (as
shown in FIG. 6, discussed later).
Exemplary Lung Unit Model and Simulated Data
An exemplary model of a lung unit is disclosed that can
be used to translate the MRI signal rise time into a quanti-
fication of specific ventilation. The exemplary model of a
lung unit corresponds to the voxel size measured with the
MRI. The variable of interest in the exemplary model is the
rate of equilibration (e.g., the rise time). For example, dead
space, water vapor and end tidal partial pressure of CO2
(PCO2), factors that change the steady state equilibrium
partial pressure of Oz W102), but remain largely constant
during, can be ignored in many instances, as described
herein. The exemplary lung unit model describes the tem-
poral behavior of the Oz concentration from the air breathing
equilibrium value to the new 100% Oz steady state.
Different ventilation-perfusion (VA/Q) ratios can result in
different steady state oxygen concentrations for both
inspired air (e.g., —range 50-100 mmHg, for VA/Q ratios
between 0.001 and 10) and 100% inspired Oz (e.g., —550 to
600 mmHg, for the same range of VA/Q ratios). These
exemplary steady state equilibrium conditions can provide
adequate (and essentially similar) contrast for all reasonable
VA/Q ratios. Further, the exemplary lung unit model is
independent of the equilibrium or steady state conditions,
e.g., it can be based on the rate of equilibration. For example,
two lung units presenting identical VA/Q ratios and different
specific ventilations are still distinguishable from each other
by the different rate of equilibration, with the one presenting
a higher SV having a faster turn-over, and thus equilibrating
faster.
For the exemplary lung unit model, assumptions can be
applied. For example, it can be assumed that a voxel
dimension (1.6x1.6 mm in the imaging plane, for a 15 mm
thick slice, volume —40 mra) is small enough such that
concentrations inside the unit at end expiration can be
considered uniform, and therefore each voxel can be treated
as a single ventilatory unit. Also, it can be assumed that the
time interval between two consecutive acquired images (>5
sec) is long enough so that equilibrium between oxygen in
the gas-phase and in solution in blood and tissues is attained
by end expiration. Using either continuous (trumpet model)
or discrete (asymmetrical branch point) models of the aci-
nus, these exemplary approaches have shown that at the
scale of existing resolution, oxygen concentration can be
constant within a single respiratory pathway. Exemplary
simulations in asymmetrical branch point models suggest
differences in 02 concentration can persist among parallel
respiratory units, yet within each unit the 02 concentration
gradient can be essentially abolished, consistent with the
exemplary assumption.
In the exemplary simulation, subjects can self gate their
breathing to the 5 s interval between consecutive image
acquisitions. Oxygen dissolves in tissues very rapidly com-
pared to this 5 s interval between images. For example, for
a normal, room air inspired breath, it takes —0.25 s for
oxygen to diffuse through a 0.5 µm thick capillary wall and
reach its equilibrium with hemoglobin in the pulmonary
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capillary, a process that includes dissolving in tissue as well
as other processes. The process of simple dissolution in
tissue thus can be assumed to be complete within this same
time frame, as in the exemplary assumption.
5 FIG. 6 shows illustrations and plots of specific ventilation
of an exemplary lung unit model. Illustration (610) and (611)
illustrate specific ventilation in the lung unit, in which Vo
represents the end-expiratory volume of the unit and AV
represents the volume increase that occurs during inspiration
10 in the lung unit. Each voxel (of an MR image) can be
simulated as a single ventilatory unit, with end expiratory
volume Vo, to which inspiration transiently adds AV during
each breath (as illustrated in FIG. 6 by illustration (610) and
illustration (611)). The initial concentration in the unit at end
15 expiration is denoted Co. C (n=1, 2, 3.... ) denotes the
concentration in the unit at end expiration after breath (n
denotes the breath number).
For example, let C," P" denote the concentration of oxy-
gen in the inspired gas for breath n during the first twenty
20 breaths the subjects are breathing air, (e.g., inspired
F1O2
-
0.21), and are then changed to a gas mixture enriched
in oxygen (e.g., F102-1-0)'
At the end of the first breath following the switch in F1021
the concentration in the unit is:
25
30
VO - CO + AV - C,iy p
Cl 
— Vo + AV
(5)
The same reasoning can be used to establish a recursive
formula for concentration after n breaths:
35 Vo-C_1 +AV-C,,p (6)
C 
Vo + AV
which in turn can be re-written as a function of the unit's
40 specific ventilation, with SV—AV/V0, as:
1 SV (7)
C 
=IT _SV C—'+ 1+SVC',
45
Eq. (7) can be used to model oxygen concentration. A
simulated response for an individual voxel can be obtained
for a given set of inspired 02 fraction breaths (e.g., inspired
oxygen fraction (650), as seen in the dotted line in FIG. 6).
5o For example, FIG. 6 also presents the time series of two
units: unit (630) with low specific ventilation (e.g., SV-0.2)
and unit (640) with high specific ventilation (e.g., SV-0.8).
A linear relationship can exist between R=1/T1 and F102-
The slope and zero crossing values reported for the RI 
-F102
55 function can result in a almost linear relationship between T1
and F1O2 in the range used in the exemplary model and
simulation (e.g., F1O2-0.21 or 1.0).
Based on numerical simulations, for the inversion time
described (e.g., 1000 msec) and the variation of TI with
60 inspired oxygen concentration, the error involved in assum-
ing that the MR signal varies linearly with oxygen concen-
tration is <3% for these exemplary implementations. The
calibration curve can be based on this assumption.
Time-Shifted Cross Correlation Between the Driving
65 Function and Simulated Units
To determine the correlation delay time, the cross corre-
lation between each simulated ventilatory unit response and
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the inspired oxygen fraction can be computed and is repre-
sented in FIG. 6 (e.g., simulated ventilatory unit response for
unit (630) and unit (640) and inspired oxygen fraction
(650)). The inspired F1O2 curve can be shifted breath-by-
breath, and the time shift that maximizes the time-shifted
crossed correlation can be a measure of how fast the unit
equilibrates, e.g., correlation delay time.
FIG. 7A shows exemplary plot (701) featuring correlation
delay time. Correlation delay time can be referred to as the
time delay that maximizes the cross-correlation of the mea-
sured signal time course from an image voxel with a square
wave representing the onset of increased inspired 02. Plot
(701) shows two exemplary correlation delay times (corre-
lation delay time (702) for 2 breaths and correlation delay
time (703) for 6 breaths) determined based on measured
signal time course (704) and rise time (705). Correlation
delay time can be used as an empirical measure of the rise
time (e.g., rise time (705) shown as dashed lines in FIG. 7A).
For example, mathematically, the cross correlation is maxi-
mized when the response is shifted by about half the rise
time, so that different rise times effectively translate to
different delays in the cross-correlation analysis. This allows
for the use of correlation delay time as an empirical index of
the rise time. This calculation can be done for the entire time
series corresponding to each image voxel. It is noted that in
some exemplary systems, a dead space, for example, in the
plumbing leading from the gas containers to the subject, can
introduce a true global delay, but this delay can be calculated
from the geometry and flow rate of the delivery system, and
eliminated before the cross-correlation analysis.
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and the simulated signal was analyzed using the time-shifted
cross correlation. The outcome of these exemplary simula-
tions for units with specific ventilation in the range specified
is shown in plot (751) of FIG. 7B. Plot (751) can include a
5 conversion tool that allows the translation of correlation
delay time (e.g., measured using the proton-MRI acquired
time series) into quantitative values of ventilation, on a
voxel-per-voxel basis.
Plot (751) shows that for a given measured correlation
10 delay time (shown on the y-axis in FIG. 713), the corre-
sponding specific ventilation can depend not only on the
specific ventilation, but also on an extrinsic delay (for
example, which can result from plumbing volume in the
inspiratory line, discussed below). In essence, any volume
15 that exists within the experimental configuration between a
subject's mouth and the valve used to change between gases
of different F1O2 can introduce a delay that can appear to
artificially reduce SV unless, properly accounted for. Thus,
it is beneficial to determine this delay by measuring respi-
20 ratory flow and inspiratory plumbing volume.
Exemplary MRI Data Collection Subjects
In exemplary experiments implementing the exemplary
method to quantify specific ventilation (SV), eight healthy
subjects (e.g., 3 female, 5 male subjects) were studied in the
25 supine posture. Table 1 presents subject characteristics (e.g.,
gender, age, height and weight) and pulmonary function data
(e.g., FEV1, FVC, and FEV1/FVC). Table 1 shows exem-
plary subject characteristics, pulmonary function data and
slope of the lung height Specific ventilation relationship
for the eight exemplary subjects.
TABLE 1
Subj Gndr
Age
(yrs)
Ht.
(m)
wt.
(kg)
FEVI
(liters)
(%
predicted)
FVC
(liters)
(%
predicted)
FEV1/FVC
(%
predicted)
-1/slope
(cm-')
Spatial
fractal
dimension
S1 M 33 1.81 81 3.99 5.17 0.77 0.020 1.15
88% 93% 95%
S2 M 26 1.85 93 4.57 5.28 0.87 0.015 1.15
92% 87% 105%
S3 F 26 1.73 68 4.13 5.04 0.82 0.031 1.15
115% 118% 96%
S4 F 39 1.62 66 3.03 3.65 0.83 0.038 1.09
101% 99% 101%
S5 F 24 1.76 92 3.08 3.65 0.84 0.043 1.11
102% 99% 102%
S6 M 52 1.86 113 4.50 5.36 0.84 0.046 1.10
105% 96% 109%
S7 M 34 1.78 83 3.84 4.98 0.77 0.021 1.16
89% 93% 95%
S8 M 28 1.70 60 4.43 5.16 0.86 0.019 1.13
107% 103% 104%
Mean SID 33±9 1.76±0.08 82±17 3.85±0.61 4.79±0.71 0.82±0.04 0.029*±0.012 1.13±0.03
100±10% 99±9% 101±5%
*Group average significantly different from zero, p = 0.0002
To relate the correlation delay time to the specific venti-
lation, an exemplary model of a lung unit can be imple-
mented that simulates the series of consecutive breaths
following a sudden change in inspired F1O2. The simulated
data for units with different specific ventilations can be used
to calibrate an exemplary signal-processing algorithm, in
which the rapidity of the increase/decrease in the MRI signal
is measured as a functional delay between the change in
F1O2 and the resulting time course of the MRI signal
intensity. The measured functional delay can be translated
into quantitative specific ventilation.
Exemplary simulations were performed in units with
specific ventilation ranging from 0.05 to 1 in steps of 0.05,
55 MRI Materials and Equipments
In exemplary experiments implementing the exemplary
method to quantify specific ventilation (SV), MRI data was
collected from the exemplary subjects using a 1.5 Tesla
Signa HDx TwinSpeed MRI system (e.g., General Electric
60 Medical Systems, Milwaukee, Wis., USA). A single sagittal
slice was selected in the right lung, e.g., in order to avoid
physiological noise arising from cardiac movements. Slice
selection was aimed at selecting the slice within the lung
presenting the largest anterior-posterior dimension, while
65 avoiding major hilar vessels.
Exemplary Specific Ventilation Imaging (SVI) Proce-
dures
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In exemplary experiments implementing the exemplary
method to quantify specific ventilation (SV), two-dimen-
sional T, weighted images were acquired using an inversion
recovery (T1=1000 msec) single shot fast spin echo (SSFSE)
sequence, with images being acquired with a half Fourier 5
acquisition (HASTE), and with a 40x40 cm field of view,
echo time of approximately 30 ms, and a 15 mm image slice
thickness. A MRI homodyne reconstruction algorithm was
used to rescale the data to a 256x256 matrix, with each voxel
thus corresponding to —1.6xl.6xl5 mm (-40 mm3). An 10
inversion time (T1) of 1000 msec, approximating T, of lung
tissue, was implemented to ensure maximal sensitivity to
changes in Oz concentration. The long repetition time used
in this single shot fast spin echo sequence (e.g., 5 s, 15
compared to the T, of blood, 1.4 s) can render the Oz
induced contrast independent of lung density. However, lung
density does alter the local signal-to-noise ratio. In the
exemplary implementations, HASTE acquisition was uti-
lized to keep the echo time short to minimize signal loss 20
observed in the lung. Images were voluntarily respiratory
gated. For example, subjects were instructed to take a
normal breath in following the noise made by the MR image
acquisition, and relax back to Functional Residual Capacity
(FRC) at a comfortable expiratory flow rate. Subjects were 25
comfortable with the default 5 s inter-breath intervals (12
breaths per minute). MR images were acquired during a
short (e.g., —hundreds of milliseconds), post-expiratory
breath hold at FRC resulting in a relatively natural respira-
tory maneuver, which was only constrained by a constant 30
breathing rate.
In exemplary experiments implementing the exemplary
method to quantify specific ventilation (SV), the addition of
02 as a contrast agent followed a block design functional
Magnetic Resonance Imaging (fMRI) approach, which can 35
be utilized for neuroimaging studies. An MR image of a lung
was acquired every 5 s, e.g., with 20 images acquired with
the subject inspiring air (21% oxygen) and 20 images while
inspiring 100% 02. This cycle was repeated 5 times, and an
additional 20 breaths of 100% oxygen were added at the end 40
of the last cycle making a total of 220 images (total imaging
time was 18 min 20 sec) for an exemplary experiment
involving each subject. Blocks of 20 breaths of air and 100%
oxygen can ensure an approach to full equilibration for the
ranges of specific ventilation and VA/Q ratios observed in 45
normal healthy subjects. Five cycles of air-oxygen can
provide an acceptable signal to noise ratio. While more or
less cycles of air-oxygen can be implemented, the exemplary
five cycles of air-oxygen were implemented as a compro-
mise between keeping the total acquisition time below 20 50
min and an improved signal to noise ratio that would result
from a longer sequence.
In exemplary experiments implementing the exemplary
method to quantify specific ventilation (SV), a face mask
(e.g., Hans Rudolph, Kans., USA, with deadspace of 73 to 55
113 mL, depending on mask size) equipped with a non-
rebreathing T-valve (e.g., with deadspace of 27.9 mL) was
fitted to the subject. One end of the T-valve was connected
to the inlet, where a remote controlled 3-way pneumatic
sliding valve (e.g., Hans Rudolph, model 8500) allowed 60
rapid switching between room air and 02 contained in a 170
liter Douglas bag (e.g., Hans Rudolph type 6170). The
inspiratory path resistance on the room air and 02 circuits
were matched to eliminate changes in FRC following
changes in inspiratory path. The outlet of the T-valve was 65
connected to a —6 m long large bore low resistance expira-
tory line, leading out of the scanner room, where expired
20
tidal volume was simultaneously measured using a Parvo-
Medics Metabolic Measurement System (ParvoMedics,
Sandy, Utah, USA).
The exemplary experimental configuration for controlling
the inspired gas (room air, 100% oxygen) introduced an
extrinsic plumbing delay in the inspired signal that can be
determined by the volume of tubing that connects the remote
control valve to the subject. This volume was made as small
as possible (e.g., 0.6 L) under constraints imposed by
working in an MRI environment. Neglecting diffusion, this
delay can be computed from each subject's tidal volume and
the tubing volume, by dividing the tubing volume by the
tidal volume. For example, in practice, this extrinsic delay
can be taken into account by computing individual inspired
fractional oxygen concentration (F1O2) time series on a
breath-by-breath basis (e.g., C, P2 in Eq. (7)), taking the
tubing volume as a delay chamber of fixed volume, through
which the inspired gas must pass. Once this extrinsic plumb-
ing delay is corrected for, what is left corresponds to the
signal intensity change over time, allowing the computation
of specific ventilation as described in the next section.
Exemplary Specific Ventilation Imaging (SVI) Data
Analysis
In exemplary experiments implementing the exemplary
method to quantify specific ventilation (SV), a time series of
the exemplary 220 images corresponding to the SVI
sequence was constructed. Quality control of the acquired
image can be performed at this stage. For example, images
in which a subject was not at FRC based on diaphragm
position compared to adjacent images can be removed from
the series and replaced by an interpolated image, constructed
from the preceding and following images. In exemplary
experiments, a region of interest was manually drawn, and
the subsequent analyses were restricted to the voxels inside
the lung. For example, the region of interest encompassed
the entire lung, yet avoided partial volume effects from
regions close to the chest wall and the diaphragm. Data
analysis was performed on a voxel-by-voxel basis, the time
course of each voxel (e.g., MRI signal intensity versus time)
was used to compute the regional correlation delay time. For
example, data analysis can be performed using Matlab
software (Mathworks, Natick, Mass.).
In exemplary experiments implementing the exemplary
method to quantify specific ventilation (SV), the correlation
delay time was computed using a shifted cross correlation
between the inspired F1O2 and the acquired signal intensity
time series. The time shifted cross correlation can be con-
sidered as a fast and simple approach to implement, fitting
only one parameter (e.g., the correlation delay time), and is
independent of the asymptotic signal intensity. For example,
by removing this extra degree of freedom, the model can
remain simple while capturing only the time course of the
transition. This can leave out, for example, the physiological
dead space, water vapor, ratios; factors that alter the steady
state CO2 concentration, and any effect of varying VA/Q
concentration, but not the time course of the transition.
Moreover, the shifted correlation delay approach can act as
a smoothing low pass filter, eliminating some of the high
frequency noise present in the exemplary data that did not
allow a direct fit of the model (Eq. (7)). In practice, for
example, the inspired F1O2 (driving function) can be corre-
lated with the time course of each voxel, and this process can
be repeated for delayed versions of the driving function
(e.g., delayed by an integer or fractional number of breaths).
The delay that maximizes the cross correlation between the
time shifted driving function and the actual voxel response
is the correlation delay time. The correlation delay time
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computed in this exemplary way can retain voxels whose
correlation with the optimal shifted inspired fractional oxy-
gen concentration is significant (P<0.05), and the null
hypothesis of no correlation can be rejected in these cases.
In voxels in which the null hypothesis is accepted, the
corresponding lung voxel can be attributed no specific
ventilation value and treated as missing data.
FIG. 8 shows an exemplary time course plot (800) of
signal intensity (801), represented by filled circles, continu-
ous lines) for one such exemplary voxel. The arbitrarily
chosen exemplary voxel plotted was located in the depen-
dent portion of the lung. The corresponding driving function
(802) representing F1O2 is also shown, represented by the
dotted line. The delay between the driving function and the
measured signal intensity is a measure of the correlation
delay time for that voxel.
Exemplary Statistical Analyses
In exemplary experiments implementing the exemplary
method to quantify specific ventilation (SV), each series of
220 breaths was considered as a single measure of specific
ventilation, computed as described above, creating for each
subject one map of specific ventilation. All the voxels
presenting a statistically significant (p<0.05) correlation
with the optimally shifted drive function were included in
the exemplary analysis. The remaining voxels were treated
as missing data. Two different exemplary analyses were
implemented, e.g., a comparison of specific ventilation by
lung thirds and a finer analysis on a cm-per-cm basis moving
up the supine lung.
For the exemplary lung thirds analysis, specific ventila-
tion was partitioned into three gravitational regions, corre-
sponding to thirds of the lung based on equal vertical extent,
e.g., the dependent portion, the intermediate region, and the
non-dependent region. The data was reduced to a subject-
by-subject average specific ventilation per lung gravitational
region. One-way ANOVA was used to compare the gravi-
tational gradient in specific ventilation across the lung
regions (e.g., the 3 levels: dependent, intermediate, and
non-dependent). Where overall significance was present,
post-hoc testing was conducted using Student's t-test.
For the exemplary finer analysis (cm-per-cm basis mov-
ing up the supine lung), linear regression was used to
evaluate the linear relationship between the vertical height
of the lung as a function of specific ventilation, e.g., by
dividing the data into isogravitational slices of 1 cm thick-
ness (-6 vertical voxels). As the exemplary subjects were
studied in the supine position, the vertical height of the lung
(isogravitational level) was measured along the anterior-
posterior axis, with zero height corresponding to the most
dependent isogravitational voxels. The linear relationships
were evaluated individually for each subject. The inter-
subject averaged specific ventilation versus lung height
values correspond to averages over vertical 1 cm regions for
the 8 subjects.
It is noted that different subjects have different anterio-
posterior lung dimensions; therefore, results were reported
only for lung heights that included data from the eight
subjects. The slope of the individual relationships between
height and specific ventilation were compared to a zero
slope using a one-group t-test.
It is noted that exemplary data are presented as mean±SD.
In the case in which data for the eight subjects were
averaged, SD corresponds to the inter-subject variability
(SD). Regarding the calculating relative dispersion, spatial
SD refers to the inter-voxel variability within a specific
ventilation map. The null hypothesis (no effect) was rejected
when P<0.05, two tailed, except where otherwise indicated.
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Exemplary statistical analyses were performed using Prism
(GraphPad, San Diego, Calif.).
Exemplary Results
General results of the exemplary experiments implement-
5 ing the exemplary method to quantify specific ventilation
(SV) included the following. Subject descriptive data and
pulmonary function measurements are presented in Table 1.
The subjects studied in the exemplary experiments had
normal spirometry, as indicated by an average
io FEV1=100±10%-predicted, FVC=99±9%-predicted, and
FEV1/FVC=101±5%-predicted (as shown in Table 1). The
exemplary subjects maintained a relatively constant expired
tidal volume throughout the experiment, e.g., averaging
0.87±0.18 L. Heart rate during SVI data acquisition aver-
15 aged 65±9 beats/min (e.g., no difference between inspiring
air and 100% oxygen), and arterial oxygen saturation mea-
sured by pulse oximetry was 97.4±1.7% while breathing
room air and increased to 97.8±1.5% during inspiration of
100% oxygen. The selected breathing rate was followed by
20 all subjects in the exemplary experiments, and tidal volume
was relatively stable throughout the 220 breaths (e.g., the
average CV for the eight subjects was 16%). Tidal volume
did not change when comparing breaths taken while inspir-
ing air and oxygen (e.g., average over the eight exemplary
25 subjects, 0.86±0.15 Liters on air, 0.87±0.17 Liters, 2-tailed
t-test paired comparison, p-0.82).
SVI results of the exemplary experiments implementing
the exemplary method to quantify specific ventilation (SV)
included the following. FIG. 8 presents the time series (e.g.,
30 time course plot (800)) of the signal intensity of a voxel
(e.g., signal intensity (801)) together with the inspired F1O2
(function (802)) for a voxel in the dependent lung region.
The exemplary experiment included five repetitions of a
block of 20 air breaths and 20 100%-oxygen breaths per-
35 formed by a subject. As shown in the figure, when the
inspired line was changed from air to 100% oxygen, signal
intensity increased; signal intensity decreased for the oppo-
site change, e.g., from 100% oxygen back to room air. After
the 5 cycles of air and 100% oxygen, twenty additional
4o breaths on 100% oxygen were added in the exemplary
experiment. Noise can be expressed as the coefficient of
variation of the steady state signal (e.g., first 20 breaths on
air, and last 20 breaths inspiring 02) averaged over the entire
lung of the 8 subjects studies. The exemplary noise was
45 determined as 22.8±1.5% for air, and 18.4±1.8% for oxygen.
In order to test the robustness of the exemplary algorithm,
the disclosed model was run with similar levels of random
noise. The average specific ventilation estimation error
introduced by 20% noise levels can be considered as
50 extremely small (e.g., average error in estimating SV
—0.003). The maximal SV estimation error was determined
to be —0.013 and was observed for very low specific
ventilation units (SV<0.02), e.g., which is below the normal
healthy range.
55 From each individual voxel response, a map of the
correlation delay time for all voxels within the lung can be
computed. An exemplary individual voxel response maps is
presented for a representative subject, as shown by map
(901) in FIG. 9A. The arrow shown indicates the direction
60 of gravity; the head is located to the right of the image, and
the diaphragm to the left. In FIG. 9A, warmer colors (e.g.,
colors trending toward red) represent portions of the lung
with a longer correlation delay time. As previously dis-
cussed, the extrinsic delay resulting from the inspiratory
65 plumbing was accounted for prior to the analysis.
Using the results presented in FIG. 713, this correlation
delay time was then translated into a quantitative measure of
US 9,750,427 B2
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specific ventilation, as shown by map (902) in FIG. 9B. In
FIG. 913, warmer colors (e.g., colors trending toward red)
represent regions of the lung with higher specific ventilation.
The quantitative measure of specific ventilation results of
the exemplary experiments implementing the disclosed
technology include average specific ventilation in a slice of
the right lung (averaged over all subjects) determined to be
0.33±0.11. Overall specific ventilation heterogeneity, as
measured by the relative dispersion, averaged 0.63±0.11;
with an individual range of 0.50 to 0.79.
The exemplary results of quantitative measure of specific
ventilation as shown in FIG. 9B demonstrates a clear vertical
(gravitational) gradient of specific ventilation is present.
Units in the dependent portions of the lung have higher
specific ventilation than those in the non-dependent portions
of the lung. This relationship is quantified in graph (1000) of
FIG. 10, which is shown in the results for the regional
dependence of specific ventilation over the eight exemplary
subjects in the three regions, e.g., nondependent region
(1001), intermediate region (1002) and dependent region
(1003). For example, a statistically significant difference in
specific ventilation was observed, with the most dependent
third of the lung having a specific ventilation of 0.42±0.14,
the intermediate third 0.29±0.10 and the non-dependent
third 0.24±0.08 (all differences, P<0.05).
An approximately linear decrease in specific ventilation
with height was observed, as evidenced in FIGS. 11A-11C.
FIG. 11A shows specific ventilation plotted against height
for one exemplary subject in plot (1110). FIG. 11B shows
specific ventilation plotted against height for each of the
eight exemplary individual subjects in plot (1120). FIG. 11C
shows the average specific ventilation plotted against height
of all eight exemplary subjects in plot (1130). The inverse of
the slope of the plotted line shown in FIGS. 11A-11C is a
measure of the decrease in specific ventilation per cm.
Specific ventilation was found to decrease 0.029±0.012/cm
on average for the eight exemplary individual subjects,
determined from the inverse of the (slope 1131) shown in
FIG. 11C.
The exemplary implementation of the disclosed 02-en-
hanced proton MR imaging technology showed regional
quantification of specific ventilation, which can, for
example, extract more information than just absence or
presence of ventilation. For example, from a physiological
standpoint, specific ventilation imaging (SVI) can show a
clear vertical (gravitational dependent) gradient with higher
values, which was demonstrated in the exemplary experi-
ments as shown in dependent lung in FIG. 10.
The spring like self-deformation of the lung, e.g., the
Slinky effect, is likely the main determinant of the gravita-
tional gradient observed in specific ventilation. However, in
the most dependent third of the supine lung there are
deviations from this overall behavior suggesting important
influences of other factors such as the non-linearity of the
pressure-volume curve of the lung, the large vessels in the
lung, and dependent airways closure.
The exemplary measurements show a linear vertical gra-
dient in specific ventilation (FIGS. 9A-4C and 11A and
11B). Dependent portions of the lung have a higher specific
ventilation that the non-dependent portions (FIG. 10). The
dependent portion of the lung partially supports the weight
of the upper portions, and thus is more "compressed."
Therefore its end-expiratory volume is smaller. Further, the
dependent portion is subject to a higher (less negative)
pleural pressure than an equivalent non-dependent region,
therefore placing it on a steeper portion of the pressure-
volume curve. For example, a change in pleural pressure
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resulting from an inspiratory effort may result in a greater
increase in volume. Both the lower initial (end-expiratory)
volume and the increased change in volume can be expected
to contribute to the higher specific ventilation observed in
5 the dependent regions of the lung, when compared to the
non-dependent.
Quantification of specific ventilation in the human lung
can be implemented by the described method of proton-MRI
SVI, which uses 02 as an inspired contrast agent.
io Implementations of the subject matter and the functional
operations described in this specification can be imple-
mented in various systems, digital electronic circuitry, or in
computer software, firmware, or hardware, including the
structures disclosed in this specification and their structural
15 equivalents, or in combinations of one or more of them.
Implementations of the subject matter described in this
specification can be implemented as one or more computer
program products, i.e., one or more modules of computer
program instructions encoded on a tangible and non-transi-
20 tort' computer readable medium for execution by, or to
control the operation of, data processing apparatus. The
computer readable medium can be a machine-readable stor-
age device, a machine-readable storage substrate, a memory
device, a composition of matter effecting a machine-read-
25 able propagated signal, or a combination of one or more of
them. The term "data processing apparatus" encompasses all
apparatus, devices, and machines for processing data,
including by way of example a programmable processor, a
computer, or multiple processors or computers. The appa-
3o ratus can include, in addition to hardware, code that creates
an execution environment for the computer program in
question, e.g., code that constitutes processor firmware, a
protocol stack, a database management system, an operating
system, or a combination of one or more of them.
35 A computer program (also known as a program, software,
software application, script, or code) can be written in any
form of programming language, including compiled or
interpreted languages, and it can be deployed in any form,
including as a stand alone program or as a module, compo-
4o nent, subroutine, or other unit suitable for use in a computing
environment. A computer program does not necessarily
correspond to a file in a file system. A program can be stored
in a portion of a file that holds other programs or data (e.g.,
one or more scripts stored in a markup language document),
45 in a single file dedicated to the program in question, or in
multiple coordinated files (e.g., files that store one or more
modules, sub programs, or portions of code). A computer
program can be deployed to be executed on one computer or
on multiple computers that are located at one site or dis-
50 tributed across multiple sites and interconnected by a com-
munication network.
The processes and logic flows described in this specifi-
cation can be performed by one or more programmable
processors executing one or more computer programs to
55 perform functions by operating on input data and generating
output. The processes and logic flows can also be performed
by, and apparatus can also be implemented as, special
purpose logic circuitry, e.g., an FPGA (field programmable
gate array) or an ASIC (application specific integrated
60 circuit).
Processors suitable for the execution of a computer pro-
gram include, by way of example, both general and special
purpose microprocessors, and any one or more processors of
any kind of digital computer. Generally, a processor will
65 receive instructions and data from a read only memory or a
random access memory or both. The essential elements of a
computer are a processor for performing instructions and
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one or more memory devices for storing instructions and
data. Generally, a computer will also include, or be opera-
tively coupled to receive data from or transfer data to, or
both, one or more mass storage devices for storing data, e.g.,
magnetic, magneto optical disks, or optical disks. However, 5
a computer need not have such devices. Computer readable
media suitable for storing computer program instructions
and data include all forms of non volatile memory, media
and memory devices, including by way of example semi-
conductor memory devices, e.g., EPROM, EEPROM, and io
flash memory devices. The processor and the memory can be
supplemented by, or incorporated in, special purpose logic
circuitry.
While this patent document contains many specifics, these
should not be construed as limitations on the scope of any 15
invention or of what may be claimed, but rather as descrip-
tions of features that may be specific to particular embodi-
ments of particular inventions. Certain features that are
described in this patent document in the context of separate
embodiments can also be implemented in combination in a 20
single embodiment. Conversely, various features that are
described in the context of a single embodiment can also be
implemented in multiple embodiments separately or in any
suitable subcombination. Moreover, although features may
be described above as acting in certain combinations and 25
even initially claimed as such, one or more features from a
claimed combination can in some cases be excised from the
combination, and the claimed combination may be directed
to a subcombination or variation of a subcombination.
Similarly, while operations are depicted in the drawings in 30
a particular order, this should not be understood as requiring
that such operations be performed in the particular order
shown or in sequential order, or that all illustrated operations
be performed, to achieve desirable results. Moreover, the
separation of various system components in the embodi- 35
ments described above should not be understood as requir-
ing such separation in all embodiments.
Only a few implementations and examples are described
and other implementations, enhancements and variations
can be made based on what is described and illustrated in 40
this patent document.
What is claimed is:
1. A computer-implemented method using magnetic reso-
nance imaging to characterize ventilation and perfusion in a
lung, comprising: 45
acquiring, using a magnetic resonance imaging (MM)
machine under the control of a processing unit, a
magnetic resonance (MR) image of the lung that
includes MR data in a voxel of the MR image, wherein
the acquiring causes the MM machine to measure a 50
breathing frequency value;
determining, by the processing unit a water density value
and a perfusion value in at least one voxel of the MR
image based on the MR data;
determining, by the processing unit from the water den- 55
sity value, an air content value in the at least one voxel;
determining, by the processing unit, a specific ventilation
value in the at least one voxel based on a time delay
between an onset of a stimulus to the lung and a
response detected in the at least one voxel; 60
determining, by the processing unit a ventilation-perfu-
sion ratio value that is the product of the specific
ventilation value, the air content value, the inverse of
the perfusion value, and the breathing frequency value;
and 65
evaluating, by the processing unit, a spatial distribution of
the specific ventilation value, perfusion value, and the
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ventilation-perfusion ratio by computing a standard
deviation of the specific ventilation value and perfusion
value;
wherein the specific ventilation value is computed by
SVI*(1—density)*f, wherein SVI represents quanti-
tative data from the MR image, (1—density) repre-
sents the air content value, and fB represents the
breathing frequency value, thereby determining
when the lung is diseased.
2. The method of claim 1, wherein the MR image is a 2D
image or a 3D image.
3. The method of claim 1, wherein the determining the
ventilation-perfusion ratio value is determined voxel-by-
voxel.
4. The method of claim 1, wherein the acquiring the MR
image uses oxygen as an inhaled contrast agent.
5. The method of claim 1, further comprising determining
an alveolar ventilation value that is the product of the
specific ventilation value, the air content value, and the
breathing frequency value.
6. The method of claim 5, further comprising:
computing a first variance in the specific ventilation
value, a second variance in the perfusion value, and a
third variance in the ventilation-perfusion ratio value;
and
generating a correlation coefficient from one or more of
the first variance, the second variance, and the third
variance.
7. The method of claim 1, further comprising producing
an image that shows the spatial distribution of ventilation,
perfusion, and ventilation-perfusion for each voxel associ-
ated with the acquired MR image.
8. The method of claim 1, wherein the spatial distribution
of ventilation, perfusion, and ventilation-perfusion is used as
an indicator of a diseased lung.
9. The method of claim 1, further comprising:
determining ventilation-perfusion matching in the lung
from at least the ventilation-perfusion ratio value.
10. The method of claim 9, wherein ventilation-perfusion
matching is used as an indicator of a diseased lung.
11. A magnetic resonance imaging system to characterize
ventilation and perfusion in a lung, comprising:
a magnetic resonance imaging machine that acquires an
MR image of the lung; and
a processing unit having a processor and a non-transitory
computer-readable storage medium having instructions
stored thereon that when executed by the processor
cause the processing unit to at least:
command the magnetic resonance imaging machine to
acquire the MR image that includes MR data in each
voxel of the MR image,
process the MR data to determine a water density value
and a perfusion value in at least one voxel of the MR
image, wherein the water density value is used to
determine an air content value,
measure a breathing frequency of the lung;
determine a specific ventilation value in the at least one
voxel based on a time delay between an onset of a
stimulus to the lung and a response detected in the at
least one voxel;
determine a ventilation-perfusion ratio value that is the
product of the specific ventilation value, the air
content value, the inverse of the perfusion value, and
the breathing frequency; and
evaluate a spatial distribution of the specific ventilation
value, perfusion value, and the ventilation-perfusion
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ratio by computing a standard deviation of the spe-
cific ventilation value and perfusion value;
wherein the specific ventilation value is computed by
SVI*(1—density)*f, wherein SVI represents quan-
titative data from the MR image, (1—density)
represents the air content value, and fB represents
the breathing frequency value, thereby determin-
ing when the lung is diseased.
12. The magnetic resonance imaging system of claim 11,
wherein the MRI system uses oxygen as an inhaled contrast
agent to acquire the MR image of the lung.
13. The magnetic resonance imaging system of claim 11
wherein the instructions, when executed by the processor,
further cause the processing unit to at least:
determine an alveolar ventilation value that is the product
of the specific ventilation value, the air content value,
and the breathing frequency.
14. The magnetic resonance imaging system of claim 13,
wherein the instructions, when executed by the processor,
further cause the processing unit to at least:
compute a first variance in the specific ventilation value,
a second variance in the perfusion value, and a third
variance in the ventilation-perfusion ratio; and
generating a correlation coefficient from one or more of
the first variance, the second variance, and the third
variance.
15. The magnetic resonance imaging system of claim 11,
wherein the instructions, when executed by the processor,
further cause the processing unit to at least:
produce an image that shows the spatial distribution of
ventilation, perfusion, and ventilation-perfusion for
each voxel associated with the acquired MR image.
16. The magnetic resonance imaging system of claim 11,
wherein the processing unit uses the spatial distribution of
ventilation, perfusion, and ventilation-perfusion as an indi-
cator of a diseased lung.
17. The magnetic resonance imaging system of claim 11,
wherein the instructions, when executed by the processor,
further cause the processing unit to at least:
determine ventilation-perfusion matching in the lung
from at least the ventilation-perfusion ratio value.
18. The magnetic resonance imaging system of claim 17,
wherein the processing unit uses ventilation-perfusion
matching as an indicator of a diseased lung.
19. A computer program product comprising a non-
transitory computer-readable storage medium having
instructions stored thereon, the instructions comprising:
code for acquiring, using a magnetic resonance imaging
(MRI) machine, an MR image of a lung that includes
MR data in a voxel of the MR image;
code for determining a water density value and a perfu-
sion value in at least one voxel of the MR image based
on the MR data, wherein the water density value is used
to determine an air content value;
code for measuring a breathing frequency value;
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code for determining a specific ventilation value in the at
least one voxel based on a time delay between an onset
of a stimulus to the lung and a response detected in the
at least one voxel;
5 code for determining a ventilation-perfusion ratio value
that is the product of the specific ventilation value, the
air content value, the inverse of the perfusion value,
and the breathing frequency value; and
code for evaluating a spatial distribution of the specific
10 
ventilation value, perfusion value, and the ventilation-
perfusion ratio by computing a standard deviation of
the specific ventilation value and perfusion value,
wherein the specific ventilation value is computed by
SVI*(1—density)*f, wherein SVI represents quanti-
tative data from the MR image, (1—density) repre-
15 sents the air content value, and fB represents the
breathing frequency value, thereby determining
when the lung is diseased.
20. The non-transitory computer-readable storage
medium of claim 19, wherein the code for acquiring the MRI
20 image of the lung includes code that uses oxygen as an
inhaled contrast agent.
21. The non-transitory computer-readable storage
medium of claim 19, further comprising code for determin-
ing an alveolar ventilation value that is the product of the
25 specific ventilation value, the air content value, and the
breathing frequency.
22. The non-transitory computer-readable storage
medium of claim 21, wherein code for determining the
alveolar ventilation value includes code for computing a first
30 variance in the specific ventilation value, a second variance
in the perfusion value, and a third variance in the ventilation-
perfusion ratio; and
generating a correlation coefficient from one or more of
the first variance, the second variance, and the third
35 variance.
23. The non-transitory computer-readable storage
medium of claim 19, wherein code for determining the
alveolar ventilation value further comprises code for pro-
ducing an image that shows the spatial distribution of
40 ventilation, perfusion, and ventilation-perfusion for each
voxel associated with the acquired MR image.
24. The non-transitory computer-readable storage
medium of claim 19, wherein code for determining the
alveolar ventilation value further comprises code for using
45 the spatial distribution of ventilation, perfusion, and venti-
lation-perfusion to indicate a diseased lung.
25. The non-transitory computer-readable storage
medium of claim 19, further comprising code for determin-
ing ventilation-perfusion matching in the lung from at least
50 the ventilation-perfusion ratio value.
26. The non-transitory computer-readable storage
medium of claim 25, wherein code for determining venti-
lation-perfusion matching further comprises code for using
ventilation-perfusion matching to indicate a diseased lung.
